Market revenue in 2022 | USD 118.5 million |
Market revenue in 2030 | USD 260.6 million |
Growth rate | 10.4% (CAGR from 2022 to 2030) |
Largest segment | Evaporative dry eye syndrome |
Fastest growing segment | Evaporative Dry Eye Syndrome |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.53% in 2022. Horizon Databook has segmented the India dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
According to Ocular Surface (2019), age, gender, place of residence (urban/rural), occupation, and socioeconomic position all have an impact on the development of dry eye disease. Owing to the chronic nature of this disease, a developing country like India is on the verge of a dry eye disease epidemic.
Moreover, 1.58% of urban residents have dry eye disease, while the urban mortality rate is 0.55%, according to the most recent census statistics. This disease is estimated to affect over 45% of India's urban population by 2030, with the prevalence of expected to climb by 1.03 (1.58%–0.55%) yearly. Dry eye disease was found to be 1.31% in rural areas, and 17 million new cases are diagnosed in rural India each year.
While extensive public health interventions are required to address this issue, identifying persons who are at high risk of dry eye disease is also critical. These factors are supporting the market growth in India.
Horizon Databook provides a detailed overview of country-level data and insights on the India dry eye syndrome treatment market , including forecasts for subscribers. This country databook contains high-level insights into India dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account